The assumption that such a tonic PLCγ-mediated signal in tumours overexpressing wt or mutant forms of the EGFR may contribute to the resistance of such tumours to ICI treatment is directly in line with recent findings from the group of Yossi Yarden [36]. This evidence concerns the gene EGFR and neoplasm.